Search

Your search keyword '"Bosquet, L."' showing total 439 results

Search Constraints

Start Over You searched for: Author "Bosquet, L." Remove constraint Author: "Bosquet, L."
439 results on '"Bosquet, L."'

Search Results

2. Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018)

7. 76P Immune checkpoint inhibitor (ICI) retreatment patterns and outcomes in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who received second-line or later (2L+) nivolumab (nivo): A French I-O optimise analysis

8. 217P Incidence and outcome of brain and/or leptomeningeal metastatic disease in HER2-low breast cancer in the French ESME cohort

10. Effects of combined physical and cognitive training on fitness and neuropsychological outcomes in healthy older adults

12. CO73 Amivantamab Versus Real-World Clinical Practice in Europe and the US for Patients With Advanced Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

16. 596P CA125 longitudinal decline kinetic is complementary to BRCA testing in first-line high grade serous ovarian carcinoma (HGSOC) patients (pts)

18. 372P Is capecitabine (CAPE) the best treatment (trt) option for estrogen receptor-positive (ER+) HER2-negative (HER2-) metastatic breast cancer (MBC) after progression on endocrine treatment (ET): An analysis of the ESME real-world database

22. Physiological and genetic control of transpiration efficiency in African rice, Oryza glaberrima Steud

26. Évaluation en vie réelle du pembrolizumab en monothérapie dans le traitement du CBNPC métastatique PD-L1-positif (TPS ≥ 50 %) en France

27. Évaluation en vie réelle du pembrolizumab en monothérapie dans le CBNPC avancé PD-L1 positif (TPS ≥ 1 %) précédemment traité, en France

28. 109P Treatment patterns in patients with advanced non-small cell lung cancer (aNSCLC) after discontinuing an immune checkpoint inhibitor (ICI) therapy in second-line or later in Germany and France

31. Exploratory analyses of surrogate endpoints in metastatic non-small cell lung cancer

36. 796P Initial management and long-term outcome of advanced low-grade serous ovarian cancer (LGSOC) exploring role of surgery and maintenance therapy in the French multicentre ESME database

40. Recommandations pour la pratique clinique 2008: prise en charge de la thrombose veineuse chez les patients atteints de cancer (méthode SOR)

43. The temporal relationship between exercise, recovery processes, and changes in performance

45. Impact de deux entrainements physiques et d’un entrainement cognitif sur la mobilité et les fonctions exécutives de personnes âgées sédentaires

46. Étude observationnelle, prospective décrivant les caractéristiques et la prise en charge de femmes atteintes d’une ostéoporose post-ménopausique traitées par Prolia® et son utilisation en pratique clinique courante en France (étude PILOTE)

49. 2. A Pharmacist-Physician Intervention Model Using a Computerized Alert System to Reduce High-Risk Medication Use in Elderly Inpatients

50. Recovery and performance in sport: Consensus statement

Catalog

Books, media, physical & digital resources